Today we're looking at titanium pigment, liver-directed cancer therapy, background screening, aesthetic injectables and foodservice distribution — five names that all reported this week.
Kronos makes the white pigment that gives paint, plastic and paper their brightness, and a leaner cost base has pulled the business back into the black. The next read is whether selling prices keep climbing.
View Chart →Delcath delivers chemotherapy straight to the liver while sparing the rest of the body, and more hospitals keep signing on to do the procedure. Watch the push into colorectal and breast cancer.
View Chart →First Advantage runs the background screening and identity checks behind corporate hiring, and demand is holding up better than the labor headlines suggest. Watch whether the raised outlook survives a slower fall.
View Chart →Evolus sells wrinkle and filler injectables to cash-pay beauty clinics, and its international footprint just expanded again. The next read is the U.S. rollout of its licensed skin-quality injectable.
View Chart →US Foods trucks ingredients and supplies to restaurants nationwide, and its most profitable customers — independent operators — are ordering at a faster clip. Watch whether that case growth holds into the fall.
View Chart →This newsletter is for informational purposes only and does not constitute financial advice. TradersPro and its contributors are not registered investment advisors. Always conduct your own due diligence before making investment decisions. Past performance is not indicative of future results.
